Effect of CYP2C19, UGT1A8, and UGT2B7 on valproic acid clearance in children with epilepsy: a population pharmacokinetic model.
Shenghui MeiWeixing FengLeting ZhuXingang LiYazhen YuWeili YangBaoqin GaoXiaojuan WuFang FangZhigang ZhaoPublished in: European journal of clinical pharmacology (2018)
TDD, BSA, and genotype might affect VPA clearance in children. The popPK models may be useful for dosing adjustment in children on VPA therapy.
Keyphrases